FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/053565 [Registered on: 05/06/2023] Trial Registered Prospectively
Last Modified On: 29/05/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Curative]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Parnayavani swarasa as an adjuvant in the management of Sheetapitta w.s.r to Urticaria 
Scientific Title of Study   A randomized controlled clinical study to evaluate the efficacy of Parnayavani swarasa as an adjuvant in the management of Sheetapitta w.s.r to Urticaria 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sushmitha Bharadwaj H G 
Designation  PG Scholar 
Affiliation  Sri Sri college of Ayurvedic science and research 
Address  Department of PG studies in Swasthavritta. Sri Sri college of Ayurvedic science and research,21st KM Kanakapura road, Udhayapura post, Bengaluru 560082. Karnataka

Bangalore Rural
KARNATAKA
560082
India 
Phone  9481765870  
Fax    
Email  sushmitabharadwaj04@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sajitha k 
Designation  Head of the department, Professor 
Affiliation  Sri Sri college of Ayurvedic science and research 
Address  Department of PG studies in Swasthavritta. Sri Sri college of Ayurvedic science and research,21st KM Kanakapura road, Udhayapura post, Bengaluru 560082. Karnataka

Bangalore Rural
KARNATAKA
560082
India 
Phone  9448415810  
Fax    
Email  sajithak96@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sajitha k 
Designation  Head of the department, Professor 
Affiliation  Sri Sri College of Ayurvedic Science and Research 
Address  Department of PG studies in Swasthavritta. Sri Sri college of Ayurvedic science and research,21st KM Kanakapura road, Udhayapura post, Bengaluru 560082. Karnataka

Bangalore Rural
KARNATAKA
560082
India 
Phone  9448415810  
Fax    
Email  sajithak96@gmail.com  
 
Source of Monetary or Material Support  
SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH 
 
Primary Sponsor  
Name  SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH 
Address  SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH,21st KM Kanakapura road, Udhayapura post, , bengaluru 560082. Karnataka 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sushmitha Bharadwaj H G  Sri Sri Ayurveda Hospital  Department of Swasthavritta, OPD number 07, O.B. Chordahalli, Udhayapura post, Bengaluru 560082. Karnataka
Bangalore Rural
KARNATAKA 
9481765870

sushmitabharadwaj04@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SRI SRI INSTITUTIONAL ETHICAL COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L509||Urticaria, unspecified. Ayurveda Condition: KUSHTHAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Parnayavani, Reference: Priya Nighantuh, Shatapushpadi varga, 11/17-18, Route: Oral, Dosage Form: Swaras/ Juice, Dose: 12(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 14 Days, anupAna/sahapAna: No, Additional Information: -to take as adjuvant with 3g Haridra khanda
2Comparator ArmDrugClassical(1) Medicine Name: Haridra kanda, Reference: Bhaisajya ratnavali of Shastri RD, 55th chapter, Sloka no. 13-17, Route: Oral, Dosage Form: Khanda /Granules, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: -warm water), Additional Information: -
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients showing minimum of 3 classical clinical feature of Sheetapitta.
2. Patients of age group between 21 to 60 years will be included irrespective of their gender, religion, marital status and socioeconomical status.
3. Subjects who are willing to participate in the study by giving the written consent
 
 
ExclusionCriteria 
Details  1.Patients having associative symptoms like vomiting, fever and suffering from any other infections or systemic disorders.
2.History of angioedema and other skin disease like psoriasis, eczema.
3.History of anaphylaxis to medicine.
4.Subjects who are pregnant and lactating.
5.Subjects who are not willing to participate in the study.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Decreased symptoms of Urticarial rashes   0th, 14th, 20th day 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in AEC count   0th, 14th, 20th day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   20/06/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Study type - Randomized Active controlled clinical study, Pre and post test study, Timing - Prospective, Masking - Open label, Grouping - Double arm, Randomization - Lottery method, Group intervention method - Parallel
 FEATURES   GROUP A - TRIAL GROUP         GROUP B - CONTROL GROUP
 SAMPLE SIZE 15 15
 INTERVENTION 3grams of Haridrakhanda and 12ml of Parnayavani Swarasa,BD 3grams of Haridrakhanda, BD
 ROUTE Oral Oral
 TIME OF ADMINISTRATION After food twice daily

 After food twice daily

 TRIAL PERIOD 14 days 14 days
 FOLLOW UP PERIOD 14th day and 20th day 14th day and 20th day
 STUDY PERIOD 20 days 20 days

 
Close